Cost-Effectiveness of α<sub>2</sub> Agonists for Intravenous Sedation in Patients With Critical Illness
Stephen Morris(University College London), Ruth Begbie(Clinical Trial Investigators), Jo Singleton(Clinical Trial Investigators), David Wellsted(Clinical Trial Investigators), Thomas W. Anderson(Clinical Trial Investigators), Timothy Walsh(Duke University), J. Kenneth Baillie(NHS Lothian), Julian Bion(Clinical Trial Investigators), R. Gennery Andrew(Clinical Trial Investigators), Alistair Nichol(University College Dublin), Corrienne McCulloch(Clinical Trial Investigators), John R. Prowle(Queen Mary University of London), Matt Stevenson(DuPont (United States)), J. Crossan(Clinical Trial Investigators), Calum Barnetson(Clinical Trial Investigators), Paul Mouncey(Intensive Care National Audit & Research Centre), Barry Williams(Clinical Trial Investigators), Natalie Pattison(University of Hertfordshire), Ruth Thompson(Clinical Trial Investigators), John Norrie(University of Glasgow), Sarah Ackroyd(Clinical Trial Investigators), Lucy MacDonald(Clinical Trial Investigators), Lucy Barclay(Clinical Trial Investigators), M Wishart(Clinical Trial Investigators), Stephen J. Brett(Imperial College London), Nazir Lone(University of Edinburgh), David Hope(Clinical Trial Investigators), Sarah A. Clark(NHS Lothian), Valeria Alicino(Clinical Trial Investigators), Nikolas Rae(Clinical Trial Investigators), Scott A. Simpson(University of Colorado Hospital), Maria Amamio(Clinical Trial Investigators), Katherine Doverman(Clinical Trial Investigators), Kate Briton(Clinical Trial Investigators), Andrew Baigey(Clinical Trial Investigators), Cathrine McKenzie(NIHR Southampton Respiratory Biomedical Research Unit), Sophie Birch(Clinical Trial Investigators), Christoper Weir(Clinical Trial Investigators), Christopher J. Weir(University of Edinburgh), Rachel Fairlie(Clinical Trial Investigators), Louise Rose(Clinical Trial Investigators)
Cited by 3
Related Papers
Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008
|Intensive Care Medicine|2007|4.9k
Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008
|Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna)|2008|3.9k
An atlas of active enhancers across human cell types and tissues
|Nature|2014|2.8k
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k